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Abstract
Purpose The aim of this study was to develop an in-depth
understanding of the rationale, experiences, evaluation and
outcomes of using Cancer Information and Support (CIS) ser-
vices in Australia, the UK and USA.
Methods Semi-structured interviews were used to gather data
between November 2015 and January 2016. Telephone inter-
views were recorded, de-identified, transcribed and themati-
cally analysed.
Ten users from each of three international CIS services
(n = 30 in total) were recruited. Participants were eligible for
inclusion if they had utilised the CIS in 2015 via telephone
contact with a cancer nurse and identified as a patient or can-
cer survivor, or friend or family member of such a person.
Results Four major themes were derived and included a total
of 25 sub-themes. Key themes included (i) drivers for access,
(ii) experience of the service, (iii) impact and (iv) an adjunct to
cancer treatment services.
Conclusions Cancer Information and Support nurses interna-
tionally act as expert navigators, educators and compassionate
communicators who ‘listen between the lines’ to enable cal-
lers to better understand and contextualise their situation and
discuss it with their healthcare team and family and friends.
Use of the service can result in reduced worry, extend support
repertoires and enable use of new knowledge and language as
a tool to getting the most from the healthcare team. The posi-
tioning of CIS alongside cancer treatment services aids fuller
integration of supportive care, benefiting both patients and
clinicians.
Keywords Supportive care . Cancer information . Oncology
nursing . Patient experience . Cancer helpline . Patient
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Introduction
Cancer Information and Support (CIS) services are
community-based sources of practical, informational and
emotional support for people affected by cancer. These ser-
vices are predominantly offered by organisations that sit
alongside, but are separate to, health services and include
non-government organisations and charities including cancer
societies. They typically interface with people affected by
cancer through telephone helplines, e-mail or internet-based
forums that act as conduits to specific supportive care pro-
grams and services. CIS services are an important resource
for cancer patients, their families and friends, health profes-
sionals and in fact anyone seeking cancer information or sup-
port, which complement information from other care pro-
viders. [1]
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CIS operate across many countries and settings [2]. The
International Cancer Information Service Group (www.icisg.
org) is a worldwide network of more than 70 organisations
that deliver cancer information and support and share best
practice to enhance CIS services. Although satisfaction for
CIS services is routinely high, [3] a recent systematic review
found that there was insufficient research regarding the level
and types of benefits that CIS services may deliver [4]. ICISG
recognises the need for CIS services to be evaluated beyond
reasons for use and customer satisfaction. There is thought to be
benefit in standardising evaluations of CIS services to cancer
treatment providers. By defining the place and value of CIS in
the pathway of cancer care, and integrating its referral in the
clinical setting, duplication may be reduced and equity of
service access promoted. There are inherent challenges
associated with evaluation of services, which include scarcity
of, or lack of knowledge about, appropriate and validated
outcome measures; practical, logistical and resource barriers;
lack of a ready to use evaluation tool; lack of research and
evaluation skills and the notion that collecting evaluation
metrics using a CIS interaction could disrupt that
interaction [5]. There is no known routine mechanism for
evaluating impact of CIS services internationally and no
agreed standard for evaluating outcomes of interacting
with CIS services. This study aimed to identify the
perceived barriers and dimensions of benefit conferred
from using a CIS as a starting point for understanding the
types of constructs from which to develop a measure for
more consistent evaluation of CIS services.
Evidencing the ideal function of CIS services is required to
map contribution to health outcomes and quality of life and to
support resource allocation decisions, service design and pro-
motional strategies in a way that supports cancer care deliv-
ered in hospitals and primary care settings. It is known that
clinician endorsement of CIS services encourages service up-
take by patients [6, 7].
Methods
Design
This study utilised a qualitative descriptive research design to
explore the rationale, experiences and outcomes of using CIS
services. Semi-structured interviews were used to gather data
between November 2015 and January 2016. The consolidated
criteria for reporting qualitative research (COREQ) checklist
[8] was used to aid both study design and reporting.
Setting and participants
The study was set at three different CIS services: Cancer
Council Victoria’s 13 11 20 Cancer Information and Support
Service (Australia), Cancer Research UK’s Cancer
Information Service and American Cancer Society’s
National Cancer Information Center. These services run to a
similar model where nurse consultants answer cancer-related
queries. There are slight differences in operation hours
(American Cancer Society is the only CIS that operates 24/
7). A triaged approach used in ACS meant that participants
were limited to those who had contact with a nurse. Ethical
approval to conduct the study was granted for all sites.
Participants were eligible for inclusion in the study if
they had used a CIS in the participating organisations in
2015 via telephone contact with a CIS nurse and had
consented to receive information regarding research pro-
jects and identified as a person affected by cancer—in-
cluding a patient or cancer survivor or friend or family
member of such a person. People affected by cancer were
aged 18 years or older and able to converse in English.
Callers who identified as health professionals or a mem-
ber of the general public seeking general interest informa-
tion were ineligible.
Procedures
Contact was made with eligible callers during the recruit-
ment phase as they called CIS or with recent CIS users
indicating an interest in participating in research. A script
was used to clarify current interest in participating and, if
affirmative, to describe the current study to the user. After
receipt of a posted or e-mailed information sheet, people
interested in participating in an interview provided verbal
consent for their contact details to be supplied to the in-
terviewer. At the midpoint of recruitment, purposive sam-
pling with particular caller types (e.g. men, cancer diag-
noses other than breast, family/friends in addition to pa-
tients) was made in an effort to provide a more diverse
sample of study participants representative of CIS users.
An interview guide (Table 1) developed for the study based
on recommendations by investigators and behavioural scien-
tists across all three study sites was used. The final interview
framework was assessed for face validity by two independent
researchers and informally piloted by the interviewer. A
scripted introduction was incorporated into the interview
guide.
All interviews were conducted via telephone by an ex-
ternal consultant based in the UK who was an experienced
nurse proficient in exploratory research with vulnerable
communities. The interviewer received a briefing on the
context of the current research, participated in teleconfer-
ence project meetings with project investigators during
the study period and was given the opportunity to debrief
after the interviews. Prior to each scheduled interview, the
interviewer was informed of the participant’s name, age,
status (person with cancer or carer/family member), and
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diagnosis (if applicable). This information was disclosed
as being known by the interviewer at the outset of the
interview and was often drawn on to build rapport and
frame context in the initial stages of the interview. As
the interviews were conducted, and in consultation with
the project team, minor revisions were made to the inter-
view framework to further explore emerging themes. Data
collection stopped after data saturation was reached.
Data preparation
Interviews were audio taped and later transcribed verbatim by
the interviewer. Identifying details were removed before the
transcripts were shared with the research team. Original inter-
view recordings were transferred securely to the respective
CIS services and subsequently deleted from the interviewer’s
files.
Categorisation of data
Two researchers (AB and AU) performed data analysis in
an iterative process, identifying key concepts directly
from the data. Initially, three transcripts (one from each
country) were independently reviewed and concepts were
theorised, compared and generated into theme lists.
Secondly, all data was read and preliminary theme lists
were expanded, discussed, sub-categorised and defined
in tandem. As transcripts were re-read and contextualised,
quotes expressing ways of imagining a particular phenom-
enon were identified as brief interpretations of constructs
and manually assigned to themes and sub-themes as mu-
tually agreed by the two researchers. The process of anal-
ysis moved from whole transcripts to the demonstrative
quotes, to the draft definitions and back again to ensure
that participants’ expressions were sufficiently appraised
and interpreted through multiple lenses and not solely
according to dominant constructs. This evolving analysis
process expanded the theme repertoire beyond the con-
structs intentionally explored in the interview framework.
For each overarching theme and definition, sub-themes
were named and defined and coded data (quotes) were
assigned. In order to verify authenticity of analysis frame-
work and assignment of data, themes, definitions and cod-
ed data were discussed among the research team and with
input from a critical reviewer (oncology research nurse)
considered a global leader in cancer control who has ex-
perience of CIS work internationally. No additional
themes were identified during this process.
Table 1 Interview guide and preamble
Interview preamble
Thank you for agreeing to participate in this research. I am conducting this interview with you today because you have recently used the cancer
information or support service from [name of organisation]. I hope to find out more about the purpose of your contact with their cancer information
and support services and how you have used the information you received. I will tape record the interview today, and please remember that you are
able to stop this interview at any time and you do not have to answer any questions that you do not want to answer. The interview should take around
45 min. Can you confirm that you are happy to proceed?
Topic Specific questions
Experience in using the CIS 1. What prompted you to access the service?
2. What were you expecting from the service?
3. How many times have you used the service?
4. What was your primary concern(s)?
5. What information or advice were you given?
6. How long did you engage with the service?
Evaluation of the CIS 7. Was your contact with the service helpful? [How or why not?]
8. Was the information you received relevant to your query?
9. Did the service assist you in the way you were hoping?
10. Did you receive any additional information or support that was helpful?
11. Would you recommend this service to others?
Outcomes following the CIS 12. Have you made contact with the support service since you first contacted them?
13. Did you feel more knowledgeable in your/others diagnosis?
14. Please describe anything you have done differently as a result of contact with this service?
[eg self-care; writing a list of questions to ask oncologist at next visit]
15. Has this change been positive? [Follow up prompt: If yes, can you give an example. If not, why not?]
16. Have you been clearer about how to communicate with your health care team or informal support network
[or that of the person you are caring for]?
17. Has using the CIS changed how distressed you feel about your/or others cancer diagnosis?
18. Have you felt better supported?
Future use 19. Would you use a CIS again?
20. Do you feel confident a CIS could address any other information or support needs?
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Results
Participant sample
As shown in Fig. 1, 82 CIS users were approached to take part
in this study from a database of 219. Of the 82 approached, 52
agreed to receive further information about the study and 30
participated in an interview (n = 10 per CIS). Overall response
rate for the study was 37%. Response rates for individual CISs
were 48% in the UK, 45% in the USA and 26% in Australia.
Demographics of the interview sample are shown in
Table 2.
Family and friends recruited were not connected with the
people affected by cancer in the sample; rather, they were
calling about people with cancer who either had not used the
CIS or were not interviewed as part of this study. Participants
had used their local CIS at least once but sometimes multiple
times and in various formats (such as via web or face to face)
in addition to speaking to a cancer nurse.
Thematic analysis
Four major themes were derived from the data and included a
total of 25 sub-themes. Themes, sub-themes, definitions and a
selection of examples of assigned data are shown in the data
analysis framework (refer to Online Resource 1).
Theme 1: drivers for access
Participants were explicitly asked about their reasons for using
CIS services. Factors or conditions that prompted initial con-
tact usually related to gaps in information or a particular emo-
tional state which contributed to a sense of needing cancer
information or support for the CIS user to be able to ‘move
on’. Often, the responses pointed to an interaction in another
part of the healthcare or wider cancer information system that
led to a lack of, or uncertainty about, clinical information
received.
Fig. 1 Recruitment of study
sample
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[Sub-theme: previous hospital experience] I’ve only used
the service a couple of times and the reason I used it was
because, in my opinion, I didn’t think that I could quite get
the response I needed at the hospital. [UK 4, cancer patient]
Some people, cited not knowing what to do or where to go
and often with no fixed agenda, turned to a CIS without any
clear knowledge of intended benefit. Participants reported
feelings of being ‘lost’ and contacted a CIS on the off chance
that it might be helpful. In other cases, the CIS user had a very
clear practical need they knew could be satisfied by making
contact with the CIS (e.g. to obtain a free wig when affected
by hair loss secondary to cancer treatment).
For family and friends, CIS was considered an accessible
place to ask clarifying or contextualising questions about a
person they were concerned for, including gaining informa-
tion relevant to someone being treated in another country.
[Sub-theme: seeking answers] There were questions that I
wanted to know. We knew in Australia that there was new
treatment available in America. They had removed the mela-
noma and weren’t doing anything else; and I thought surely he
should be having follow up treatment? What about this new
treatment that we’ve heard about in America^ Why isn’t he
having that? What about the chances of melanoma coming
back as stage IV melanoma? [AUS 2, sister]
CIS services were accessed by people not understanding
what the cancer meant for them, either because they had too
much information and sought clarity or because the shock of
diagnosis meant questions took some time to be formulated.
[Sub-theme: stunned and confused]From our point of view,
not so much the first diagnosis but the third and the prognosis
took us by surprise. Looking back, if I had any questions then I
could have done it. But we just did not. [UK 1, son]
Theme 2: experience of using the CIS
CIS users described a range of experiences and benefits of
using CIS services which served to offer an additional
point of access, clarify information and help to identify
new potential information and support avenues for further
exploration. Participants experienced CIS nurses as reli-
able experts, compassionate communicators and sensitive
problem solvers, which enhanced their trust and comfort
in the service. CIS nurses were accessible, accommodat-
ing and gave callers the space to be heard. Notably, the
nurses were reported to listen and sought to understand
more than just the clinical context for the caller in order to
provide most salient and tailored information and support.
As a result of the nurses’ role as a navigator, callers often
reported ‘bonuses’ in information, support, education or
expansion of a caller’s support repertoire.
[Sub-theme: a trustworthy reliable source] She introduced
herself and explained that she was a nurse and straightaway
that gave me confidence; it helped me feel secure. [UK 10,
cancer patient]
[Sub-theme: expert knowledge] Having that conviction to
talk met by someone who has a whole wealth of experience is
actually really important [UK 9, cancer patient]
Theme 3: impact
For participants, nurses helped to reduce worry, fear or bur-
den, through reassurance, normalising or meeting information
needs.
[Sub-theme: reducing worry or burden] Yeah and it makes
me relaxed, like peaceful that there’s somebody to go to, that
you’re not stuck somewhere with a question in your mind
that’s going to make you not sleep for five days, and that’s
when you call and you give them the specifics and you can
work it out for that. [USA10, cancer patient]
The interaction with the CIS often resulted in improved
confidence and competence to manage own health. This came
about by better knowledge of systems, supports and the lan-
guage with which to participate in conversations about cancer.
This resulted in enhanced productivity of conversations with
family, friends and the healthcare team.
[Sub-theme: preparing and informing my family] They’ve
got some fantastic booklets, for example I had to use one,
Table 2 Demographics of interview sample
CCVa CRUKb ACSc Total
Person with cancer 6 4 9 19 (63%)
Female 5 3 8 16












Familial adenomatous polyposis 1
Carer or family member 4 6 1 11 (37%)
Female 4 4 0 8
Male 0 2 1 3
Mean age 53
a Cancer Council Victoria
b Cancer Research UK
cAmerican Cancer Society
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Talking to Children About Cancer. I found that helpful. I
talked to my daughter about what is happening and what is
going to happen, so she was prepared. [AUS 3, cancer
patient]
Callers felt that through information obtained from the CIS,
they may be able to engage in their health or the health of
friends and family in a more empowered way, not only feeling
both confident and competent to manage own health but also
through extending their support repertoire.
[Sub-theme: knowledge as power] I picked up some med-
ical jargon and buzzwords from the CIS that I could actually
speak to the urologist. Sometimes when you engage in a con-
versation with an expert and you are able to throw back some
of the terminology then they will say ‘well, it seems that you
have done your research’. They can’t bamboozle you because
you have already become a little bit more educated. So, the
CIS provided the literature to explain something in very sim-
ple language. [AUS 10, cancer patient]
Theme 4: an adjunct to cancer treatment services
Participants identified CIS as a clear categorisation outside of
but as a useful adjunct to the support from cancer treatment
services. These supports were seen as complementary and
additive to those received from health services. Participants
expressed that optimal benefit cannot be fully realised without
the two sources of support being drawn on, integrated and
respected.
[Sub-theme: positioning and integration] I don’t know why
it is that I didn’t know about the CIS in the beginning before
the current oncologist…getting the word out is probably the
most important thing, getting it out to every oncologist. They
do their part and we need more, we need more. [USA 6,
cancer patient]
Participants clearly distinguished between the scope of
practice of the healthcare team responsible for the patient’s
individual medical needs and the CIS who work to identify
and address broader cancer informational, emotional and prac-
tical support needs and assist the caller’s interactions with
their cancer care team.
[Sub-theme: boundaries] I asked, should I continue to be
taking Tamoxifen and she very directly sent me back to the
medical people to ask that of a consultant—it’s not for her to
say. I still don’t have an answer but I’m going to see a breast
consultant now about the medication. [UK10, cancer patient]
Sometimes, CIS was the only accessible source of non-
clinical but essential supportive care for cancer patients
and their friends and families. It was viewed as a point
of access not available in the hospital setting. CIS was
viewed as a ‘gap filler’—a place to go outside of set
appointment times while waiting for the next stage of
care.
Discussion
CIS nurses internationally act as navigators, educators and
therapeutic communicators who listen between the lines
to enable callers to better understand and contextualise
their situation, its implications and the support options
available to them. CIS services work to both interpret
and enhance the meaning of information gathered from
other sources and to increase a person’s informational,
emotional and practical support repertoire. Use of the ser-
vice can support heath literacy and empower people af-
fected by cancer to better manage their own health and
wellbeing. Central to this is support to get the most from
the healthcare team. CIS is a useful adjunct to the clinical
cancer environment which holds rightful responsibility for
individual medical treatment. CIS nurses are found to be
more accessible for cancer information and support needs
with regard to the amount of time available, emotional
approachability and openness to spontaneous contact from
anyone who has a question about cancer.
This study is limited to English-speaking participants
from Australia, UK and USA. As such, it does not repre-
sent the use and impact of CIS services across all cancer
contexts or cultures, nor does it explore the use and im-
pact of CIS by people who experience language barriers
within their own health services. Different CIS users will
also have different needs based on clinical, personal and
geographical characteristics. Future research can draw on
these differences to best characterise the usefulness of CIS
services for different user profiles. Additionally, people
with a more positive view of the service or those with
higher levels of engagement in own health or the care of
another person may be more likely to participate in an
evaluation study through a bias towards more positive
perspectives. However, participation in this study in all
three countries was made available to any user of CIS
so people with a strong negative view were equally able
to participate. Reasons for declining participation mainly
pertained to being too busy. It is possible participants
were inclined to reflect on positive outcomes of their ex-
perience with a CIS as a result of terminology used in the
interview guide. However, study rigour was enhanced by
using only one interviewer to conduct all interviews
across the three countries and by seeking independent
and critical review of qualitative data analysis in order
to minimise interpretation bias and strengthen inter-rater
reliability. This study design and execution required effec-
tive collaboration to simultaneously evaluate impact of
multiple CIS services. This work enables application of
findings for CIS service improvement internationally.
This work extends the knowledge contributed by pre-
vious studies which focused mainly on customer satisfac-
tion [9], reasons for using a CIS [10, 11], and functions of
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a CIS [12] and suggested marketing strategies for CIS
services to make clearer what is available to patients and
how the service is staffed [13]. Work by Livingston and
colleagues [14] measured how cancer support programs
empower survivors with regard to indicators such as feel-
ing more in control of illness, feeling more confident
about seeking support and being able to navigate around
the healthcare system. The current study contributes infor-
mation from which a pool of indicators for more consis-
tent evaluation of CIS services can be derived. Novel in
the current study is the new insight into how what is
experienced in a CIS contact can then be used to facilitate
beneficial and engaging interactions in the clinical context
or with other support networks. This study was a first step
to inform a more consistent approach to evaluating CIS
services. Although it was beyond the scope of this study
to explore in detail the extent of congruence in experience
and outcomes for CIS users across countries, more simi-
larities than differences were described across the partic-
ipant sample. Despite key differences in healthcare
models in Australia, UK and USA, the theme of CIS be-
ing an accessible mechanism for information and support
when resource constraints limited extensive support seek-
ing from cancer treatment specialists was common.
This study reinforces that there are distinct and com-
plementary roles for cancer treatment and CIS services
respectively, in supporting people affected by cancer.
CIS users identify and respect these differences and seek
to feel valued and heard throughout all components of the
cancer support system as they draw on multiple sources of
information and care. This study supports a sense of in-
terdependence of CIS on the clinical environment and
vice versa where optimal benefit from healthcare provi-
sion cannot be realised without the two sources of support
being drawn on, integrated and mutually respected by
those who work within it.
Study implications show there is a need to improve
continuity of care and equity in access between cancer
treatment services and CIS whilst respecting professional
boundaries, in order to optimise cancer care and utilise the
health system appropriately. With an in-depth understand-
ing of the experience of engaging with CIS, these data can
now be used to further inform the development of more
consistent approaches to evaluating CIS services. There is
a need to test these identified themes in new countries and
languages enabling the exploration of differences between
services to improve the specificity of future tools
developed.
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